Literature DB >> 12739746

Management of post-menopausal osteoporosis: something new on the horizon?

M L Brandi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12739746     DOI： 10.1007/BF03345147

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  15 in total

Review 1.  Bone matters: are density increases necessary to reduce fracture risk?

Authors:  K G Faulkner
Journal:  J Bone Miner Res       Date:  2000-02       Impact factor: 6.741

2.  Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.

Authors:  T Schnitzer; H G Bone; G Crepaldi; S Adami; M McClung; D Kiel; D Felsenberg; R R Recker; R P Tonino; C Roux; A Pinchera; A J Foldes; S L Greenspan; M A Levine; R Emkey; A C Santora; A Kaur; D E Thompson; J Yates; J J Orloff
Journal:  Aging (Milano)       Date:  2000-02

Review 3.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

Review 4.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.

Authors:  P Lips
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

5.  Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial.

Authors:  R Lindsay; F Cosman; R A Lobo; B W Walsh; S T Harris; J E Reagan; C L Liss; M E Melton; C A Byrnes
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

6.  Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.

Authors:  Marc C Hochberg; Susan Greenspan; Richard D Wasnich; Paul Miller; Desmond E Thompson; Philip D Ross
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.

Authors:  S T Harris; E F Eriksen; M Davidson; M P Ettinger; A H Moffett; D J Baylink; C E Crusan; A A Chines
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.

Authors:  T Mashiba; C H Turner; T Hirano; M R Forwood; C C Johnston; D B Burr
Journal:  Bone       Date:  2001-05       Impact factor: 4.398

9.  Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Authors:  Ian R Reid; Jacques P Brown; Peter Burckhardt; Zebulun Horowitz; Peter Richardson; Ulrich Trechsel; Albert Widmer; Jean-Pierre Devogelaer; Jean-Marc Kaufman; Philippe Jaeger; Jean-Jacques Body; Maria Luisa Brandi; Johann Broell; Raffaele Di Micco; Andrea Riccardo Genazzani; Dieter Felsenberg; Joachim Happ; Michael J Hooper; Jochen Ittner; Georg Leb; Hans Mallmin; Timothy Murray; Sergio Ortolani; Alessandro Rubinacci; Maria Saaf; Goran Samsioe; Leon Verbruggen; Pierre J Meunier
Journal:  N Engl J Med       Date:  2002-02-28       Impact factor: 91.245

10.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors:  Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272
View more
  2 in total

1.  A newly developed snack effective for enhancing bone volume.

Authors:  Junji Ohtani; Rene Arturo Marquez Hernandez; Hiroko Sunagawa; Tadashi Fujita; Toshitsugu Kawata; Masato Kaku; Masahide Motokawa; Natsumi Tsuka; Hiroyuki Koseki; Yayoi Matsuda; Hidetaka Hayashi; Sara Abedini; Kazuo Tanne
Journal:  Nutr J       Date:  2009-07-03       Impact factor: 3.271

2.  Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study.

Authors:  Francesco Massart; Francesca Marini; Gerolamo Bianchi; Salvatore Minisola; Giovanni Luisetto; Antonella Pirazzoli; Sara Salvi; Dino Micheli; Laura Masi; Maria Luisa Brandi
Journal:  Reprod Biol Endocrinol       Date:  2009-04-22       Impact factor: 5.211
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.